Abstract
The type 2 serotonin (5-HT2) receptor subfamily is known to couple to phosphoinositide hydrolysis (PI) and the subsequent mobilization of intracellular Ca2+, as well as the release of arachidonic acid (AA). Less is known of 5-HT2-mediated activation of the mitogen-activated protein kinase (MAPK) or extracellular signal-regulated kinase (ERK1/2) signaling. The present study measured the relative efficacies and potencies of 5-HT agonists to activate ERK2 in non-neuronal cells expressing recombinant human 5-HT2A, 5-HT2B, and 5-HT2C(ISV) receptors. 5-HT agonists stimulated ERK2 activity via all three 5-HT2 subtypes. There were no meaningful differences in the potencies or relative efficacies of these agonists to affect ERK2 activity vs. PI accumulation or Ca2+ mobilization, suggesting that these pathways may be sequentially linked. Indeed, ERK2 activity was very sensitive to PKC inhibition and calcium chelation and insensitive to tyrosine kinase and PI-3-kinase inhibition. 5-HT2 receptors efficiently couple to MAPK activation via sequential PI hydrolysis, and Ca2+ mobilization. This profile differs from reports of “agonist-directed trafficking of receptor stimulus” between PI/Ca2+ and AA pathways activated by 5-HT2 receptors.
Similar content being viewed by others
References
Banes A, Florian JA, Watts SW (1999) Mechanisms of 5-hydroxytryptamine2A receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle. J Pharmacol Exp Ther 291:1179–1187
Brown P, Gerfen CR (2006) Plasticity within striatal direct pathway neurons after neonatal dopamine depletion is mediated through a novel functional coupling of serotonin 5-HT2 receptors to the ERK 1/2 map kinase pathway. J Comp Neurol 498:415–30
Baxter G, Kennet G, Blaney F, Blackburn T (1995) 5-HT2 receptor subtypes: a family re-united. Trends Pharmacol Sci 16:105–109
Berg KA, Maayani S, Goldfarb J, Scaramellini C, Leff P, Clarke WP (1998) Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol Pharmacol 54:94–104
Berg KA, Cropper JD, Niswender CM, Sanders-Bush E, Emeson RB, Clarke WP (2001) RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. Br J Pharmacol 134:386–392
Bonhaus DW, Bach C, DeSouza A, Salazar FH, Matsuoka BD, Zuppan P, Chan HW, Eglen RM (1995) The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. Br J Pharmacol 115:622–628
Chang M, Zhang LS, Tam JP, Sanders-Bush E (2000) Dissecting G protein-coupled receptor signaling pathways with membrane-permeable blocking peptides: endogenous 5-HT2C receptors in choroid plexus epithelial cells. J Biol Chem 275:7021–7029
Chengalvala M, Kostek B, Frail DE (1999) A multi-well filtration assay for quantification of inositol phosphates in biological samples. J Biochem Biophys Methods 38:163–70
Conn PJ, Sanders-Bush E (1984) Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex. Neuropharmacology 23(8):993–996
Cussac D, Newman-Tancredi A, Duqueyroix D, Pasteau V, Millan MJ (2002) Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine (2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking. Mol Pharmacol 62:578–589
Davies SP, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95–105
Egan C, Grinde E, Dupre A, Roth BL, Hake M, Teitler M, Herrick-Davis K (2000) Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors. Synapse 235:144–50
Felder CC, Kanterman RY, Ma AL, Axelrod J (1990) Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. Proc Natl Acad Sci U S A 87:2187–2191
Fitzgerald LW, Conklin DS, Krause CM, Marshall AP, Patterson JP, Tran DP, Iyer G, Kostich WA, Largent BL, Hartig PR (1999a) High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action. J Neurochem 72:2127–2134
Fitzgerald LW, Iyer G, Conklin DS, Krause CM, Marshall A, Patterson JP, Tran DP, Jonak GJ, Hartig PR (1999b) Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology 21:82S–90S
Fitzgerald LW, Burn TC, Brown BS, Patterson JP, Corjay MH, Valentine PA, Sun J-H, Link JR, Abbaszade I, Hollis JM, Largent BL, Hartig PR, Hollis GF, Meunier PC, Robichaud AJ, Robertson DW (2000) Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Mol Pharmacol 57:75–81
Florian JA, Watts SW (1998) Integration of mitogen-activated protein kinase kinase activation in vascular 5-hydroxytryptamine2A receptor signal transduction. J Pharmacol Exp Ther 284(1):346–355
Galandrin S, Oligny-Longpré G, Bouvier M (2007) The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol Sci 28:423–430
Gay EA, Urban JD, Nichols DE, Oxford GS, Mailman RB (2004) Functional selectivity of D-2 receptor ligands in a Chinese hamster ovary hD(2L) cell line: evidence for induction of ligand-specific receptor states. Mol Pharmacol 66:97–105
Girault JA, Valjent E, Caboche J, Hervé D (2007) ERK2: a logical AND gate critical for drug-induced plasticity. Curr Opin Pharmacol 7:77–85
Greene EL, Houghton O, Collinsworth G, Garnovskaya MN, Nagai T, Sajjad T, Bheemanathini V, Grewal JS, Paul RV, Raymond JR (2000) 5-HT2A receptors stimulate mitogen-activated protein kinase via H2O2 generation in rat renal mesangial cells. Am J Physiol Renal Physiol 278:F650–F658
Hershenson MB, Chao T-SO, Abe MK, Gomes I, Kelleher MD, Sloway J, Rosner MR (1995) Histamine antagonizes serotonin and growth factor induced mitogen-activated protein kinase activation in bovine tracheal smooth muscle cells. J Biol Chem 270:19908–19913
Jerman JC, Brough SJ, Gager T, Wood M, Coldwell MC, Smart D, Middlemiss DN (2001) Pharmacological characterization of human 5-HT2 receptor subtypes. Eur J Pharmacol 414:23–30
Kenakin T (2007a) Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors. Trends Pharmacol Sci 28:407–415
Kenakin T (2007b) Functional selectivity through protean and biased agonism: who steers the ship? Mol Pharmacol 72:1393–1401
Launay JM, Guillaume B, Bondoux D, Callebert J, Choi DS, Loric S, Maroteaux L (1996) Ras involvement in signal transduction by the serotonin 5-HT2B receptor. J Biol Chem 271:3141–3147
Leysen JE (2004) 5-HT2 Receptors. Curr Drug Targets CNS Neurol Disord 3:11–26
Moya PR, Berg KA, Gutiérrez-Hernandez MA, Sáez-Briones P, Reyes-Parada M, Cassels BK, Clarke WP (2007) Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors. J Pharmacol Exp Ther 321:1054–1061
Porter RH, Benwell KR, Lamb H, Malcolm CS, Allen NH, Revell DF, Adams DR, Sheardown MJ (1999) Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B, and 5-HT2C receptors in CHO-K1 cells. Br J Pharmacol 128:13–20
Pierce KL, Luttrell LM, Lefkowitz LJ (2001) New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 20:1532–1539
Quinn JC, Johnson-Farley NN, Yoon J, Cowen DS (2002) Activation of extracellular-regulated kinase by 5-hydroxytryptamine2A receptors in PC12 cells is protein kinase C-independent and requires calmodulin and tyrosine kinases. J Pharmacol Exp Ther 303:746–752
Roth BL, Nakaki T, Chuang DM, Costa E (1984) Aortic recognition sites for serotonin (5HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover. Neuropharmacology 23(10):1223–1225
Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka BK, Weinstein H, Javitch JA, Roth BL, Christopoulos A, Sexton P et al (2007) Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 320:1–13
Wainscott DB, Sasso DA, Kursar JD, Baez M, Lucaites VL, Nelson DL (1998) [3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor. Naunyn-Schmiedeberg’s Arch Pharmacol 357:17–24
Werry TD, Gregory KJ, Sexton PM, Christopoulos A (2005) Characterization of serotonin 5-HT2C receptor signaling to extracellular signal-regulated kinases 1 and 2. J Neurochem 93:1603–1615
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Knauer, C.S., Campbell, J.E., Chio, C.L. et al. Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors. Naunyn-Schmied Arch Pharmacol 379, 461–471 (2009). https://doi.org/10.1007/s00210-008-0378-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-008-0378-4